OUR SOCIAL
RESPONSIBILITY

GeneLife and Genesis Healthcare aspire to contribute to the advancement of medical science and genetic research. We conduct joint research with local and international institutions with the aim of conducting more research and accelerating drug discovery for rare inherited and lifestyle diseases.

GENESIS ASIA 1,000 PROJECT - MAPPING RARE DISEASES

The aim of the project is to profile 1,000 whole genomes of Asian patients with rare diseases.

Genesis Healthcare invites public participation of patients and researchers / research institutions from Japan, Singapore, Taiwan, Hong Kong, Indonesia, Malaysia, Thailand and Philippines.

In the absence of an existing genome database focusing on Asia, Genesis Healthcare will support researchers in Asia to identify causes of rare diseases and accelerate new drug discovery. Genesis Healthcare will provide the whole genome sequencing for 1,000 patients free of cost and aim to cover the following diseases:

  • Alzheimer’s disease
  • Autism
  • Amyotrophic lateral sclerosis (ALS)
  • Myelopathic muscular atrophy
  • Parkinson’s disease
  • Multiple sclerosis / Neuromyelitis optica
  • Moya moya disease
  • Systemic lupus erythematosus (SLE)
  • Congenital myopathy
  • Tuberous sclerosis
  • And other rare diseases

If you have any of the above diseases or any other rare disease and would like to contribute to genetic research, please write in to info@genesis-healthcare.asia with the subject “Genesis Asia 1,000 Project”.


DELVING INTO TYPE 2 DIABETES

In our efforts to gather more data and do more in-depth research about type 2 diabetes, GeneLife and Genesis Healthcare are offering a discounted price of S$149 for our Genesis 2.0 at-home DNA test kit for anyone diagnosed with type 2 diabetes.

This special offer is open to anyone 18 years old or above. A proof of condition is required in order to be eligible for this offer.

To learn more about this offer, please contact info@genesis-healthcare.asia with the subject “Type 2 Diabetes Research”